The St. Luke’s Foundation is excited to bring back the Circle of Light Gala again after a break during COVID. The Lake Superior Ballroom is being transformed for the Friday evening event, which is the ...

NBC Select independently determines what we cover and recommend. When you click on or buy through our links, we earn a commission. Learn more. Cory Fernandez Commerce Editor Target just announced the ...

Hyperliquid's new USDC arrangement with Coinbase and Circle lets the protocol capture most reserve income generated by stablecoin deposits on the platform. Analysts say the deal could create ...

If you've ever wanted to integrate OpenAI's ChatGPT features into your Java programs, you'll be happy to learn that Spring AI has made the process easier than ever. And it's not just easier to connect ...

D.C. police have arrested two suspects in the gruesome killing of a man in February who was found bound, beaten, strangled and burned inside his condo in the city’s upscale Logan Circle neighborhood ...

Circle shares fell 20% as investors reacted to the latest version of a bill known as the Clarity Act. The proposed legislation could ban stablecoin issuers from paying yield to customers just for ...

Circle’s USD Coin is gaining momentum as a digital alternative to real U.S. dollars. It has plenty of room to grow, but it probably isn’t a millionaire-maker stock. Circle's USD Coin, a cryptocurrency ...

Circle's USD Coin, a cryptocurrency pegged to the U.S. dollar, is used to settle cross-border transactions at faster and cheaper rates than conventional interbank transfers. It's also an easy way for ...

Image source: Getty Images. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...